The association of patient age with postoperative morbidity and mortality following resection of intracranial tumors.
Age
Functional status
Intracranial tumor
KPS
Outcome
Risk factor
Journal
Brain & spine
ISSN: 2772-5294
Titre abrégé: Brain Spine
Pays: Netherlands
ID NLM: 9918470888906676
Informations de publication
Date de publication:
2021
2021
Historique:
received:
13
07
2021
revised:
10
10
2021
accepted:
14
10
2021
entrez:
17
10
2022
pubmed:
18
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
The postoperative functional status of patients with intracranial tumors is influenced by patient-specific factors, including age. This study aimed to elucidate the association between age and postoperative morbidity or mortality following the resection of brain tumors. A multicenter database was retrospectively reviewed. Functional status was assessed before and 3-6 months after tumor resection by the Karnofsky Performance Scale (KPS). Uni- and multivariable linear regression were used to estimate the association of age with postoperative change in KPS. Logistic regression models for a ≥10-point decline in KPS or mortality were built for patients ≥75 years. The total sample of 4864 patients had a mean age of 56.4 ± 14.4 years. The mean change in pre-to postoperative KPS was -1.43. For each 1-year increase in patient age, the adjusted change in postoperative KPS was -0.11 (95% CI -0.14 - - 0.07). In multivariable analysis, patients ≥75 years had an odds ratio of 1.51 to experience postoperative functional decline (95%CI 1.21-1.88) and an odds ratio of 2.04 to die (95%CI 1.33-3.13), compared to younger patients. Patients with intracranial tumors treated surgically showed a minor decline in their postoperative functional status. Age was associated with this decline in function, but only to a small extent. Patients ≥75 years were more likely to experience a clinically meaningful decline in function and about two times as likely to die within the first 6 months after surgery, compared to younger patients.
Identifiants
pubmed: 36247402
doi: 10.1016/j.bas.2021.100304
pii: S2772-5294(21)00304-0
pmc: PMC9560674
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100304Informations de copyright
© 2021 The Authors.
Références
J Neurosurg. 2003 Sep;99(3):467-73
pubmed: 12959431
J Neurosci Rural Pract. 2012 Jan;3(1):28-35
pubmed: 22346187
Cancer. 2013 Mar 1;119(5):1058-64
pubmed: 23065678
J Clin Neurosci. 2011 Jan;18(1):34-8
pubmed: 20851611
J Clin Oncol. 2012 Feb 1;30(4):419-25
pubmed: 22203767
J Neurooncol. 2018 Nov;140(2):385-391
pubmed: 30076585
Cell Mol Life Sci. 2015 Sep;72(17):3323-42
pubmed: 25985759
AJNR Am J Neuroradiol. 2011 Sep;32(8):1420-5
pubmed: 21885713
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Surg Neurol. 2007 Oct;68(4):407-11; discussion 411
pubmed: 17586023
Neurosurg Focus. 2015 Dec;39(6):E14
pubmed: 26621412
J Neurooncol. 2013 Sep;114(2):219-27
pubmed: 23737294
Int J Radiat Oncol Biol Phys. 1999 Mar 1;43(4):795-803
pubmed: 10098435
Neurosurgery. 2018 Dec 1;83(6):1249-1259
pubmed: 29481613
Surg Neurol. 2007 Oct;68(4):412-20; discussion 420
pubmed: 17905066
Anesthesiology. 2018 Dec;129(6):1111-1120
pubmed: 30234580
J Neurosurg. 2020 Jun 12;134(6):1743-1750
pubmed: 32534490
World Neurosurg. 2018 Feb;110:e287-e295
pubmed: 29113899
ISRN Surg. 2011;2011:207103
pubmed: 22084749
J Neurooncol. 2017 Oct;135(1):161-171
pubmed: 28685405
Biol Sex Differ. 2012 Jan 25;3:3
pubmed: 22277186
Ann Transl Med. 2015 Jun;3(9):121
pubmed: 26207249
J Neurooncol. 2018 Sep;139(2):441-448
pubmed: 29721751
JAMA. 1998 May 13;279(18):1474-6
pubmed: 9600483
Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1001-6
pubmed: 10863071
J Neurosurg. 2013 Apr;118(4):786-98
pubmed: 23176331
World Neurosurg. 2018 Jan;109:e16-e23
pubmed: 28919230